buprenorphine
← Previous: bumetanide | 🏠 All Substances | 📊 Complete Table | Next: buserelin →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) |
| Added to Database | December 30, 2025 |
| Source Last Updated | March 15, 2024 |
| GUID | 9ea57a6c-e9f3-4e35-a7eb-aaee6550f4ee |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 40D3SCR4GZ · CAS: 52485-79-7
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C29H41NO4 |
| Molecular Weight | 467.6 g/mol |
| IUPAC Name | (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol |
| InChIKey | RMRJXGBAOAMLHD-IHFGGWKQSA-N |
📊 Complete Table | 🏠 All Substances
Substance 241 of 880